Detalles de la búsqueda
1.
On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses?
Digestion
; 88(1): 56-63, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23880545
2.
Assessment of the Asian Neurogastroenterology and Motility Association Chronic Constipation Criteria: An Asian Multicenter Cross-sectional Study.
J Neurogastroenterol Motil
; 23(2): 262-272, 2017 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27764907
3.
[Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease]. / Application des recommandations de la conférence de consensus devant des symptômes ORL, respiratoires ou des douleurs thoraciques considérés comme dus à un reflux gastro-Åsophagien.
Presse Med
; 42(5): e125-32, 2013 May.
Artículo
en Francés
| MEDLINE | ID: mdl-23414966
4.
Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole.
Eur J Gastroenterol Hepatol
; 23(10): 845-51, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21900784
Resultados
1 -
4
de 4
1
Próxima >
>>